Physician profile
Gary F Jaffe
NPI 1962455824
$1,746.01
in general payments reported to CMS, 2019-2025
18 companies · $763 in 2025
The $763 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $126 · 2021: $152 · 2022: $260 · 2023: $141 · 2024: $118 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,022.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,022.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $572.08 | 2023-2025 | |
| Horizon Therapeutics Plc | $387.78 | 2019-2023 | Tepezza |
| Amgen INC. | $122.50 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $120.11 | 2019 | |
| Sight Sciences, INC. | $84.55 | 2021 | |
| Alcon Vision LLC | $82.67 | 2022-2025 | Rocklatan, Tryptyr |
| Aerie Pharmaceuticals, INC. | $77.02 | 2019-2020 | |
| Biotissue Holdings INC. | $55.95 | 2024-2025 | |
| Allergan, INC. | $45.00 | 2020 | |
| Astellas Pharma US INC | $35.81 | 2024 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.84 | 2021 | |
| Ani Pharmaceuticals, INC. | $24.29 | 2025 | Purified Cortrophin Gel |
| Sun Pharmaceutical Industries INC. | $23.73 | 2020 | |
| Bausch & Lomb Americas INC. | $22.14 | 2025 | Vyzulta |
| Tarsus Pharmaceuticals, INC. | $20.40 | 2025 | Xdemvy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $18.27 | 2025 | Oxervate |
| Shire North American Group INC | $15.12 | 2019 | |
| Thea Pharma INC. | $13.75 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Jaffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.